Lamictal XR 100 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FE8X8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,211
Award facts
- Contract value 100% obligated
- $15,210.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Lamictal XR 100 mg tablets (30-count units) with a ceiling value of $15,210.85. This firm fixed-price delivery order, with an ultimate completion date of December 17, 2025, represents a competitive award with no set-aside designation. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contracting portfolio with the DLA and related defense health agencies. The company's extensive experience fulfilling federal medical supply requirements across multiple therapeutic domains, combined with its competitively awarded contract history, demonstrates its capability to support critical pharmaceutical needs for military and veteran healthcare systems. Lamictal XR (lamotrigine extended-release), an antiepileptic and mood-stabilizing medication, represents the type of specialized pharmaceutical commodity that AmerisourceBergen routinely delivers through its DLA prime vendor arrangements to support the Defense Health Agency and U.S. Coast Guard healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FE8X8?
SPE2DR26FE8X8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FE8X8 worth?
The government has obligated $15,211 on SPE2DR26FE8X8.
Is contract SPE2DR26FE8X8 an order under another contract?
Yes. SPE2DR26FE8X8 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FE8X8 competed?
The extent of competition for SPE2DR26FE8X8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award